<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35022222</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2373-2873</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Feb</Month>
            </PubDate>
          </JournalIssue>
          <Title>Cold Spring Harbor molecular case studies</Title>
          <ISOAbbreviation>Cold Spring Harb Mol Case Stud</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Whole-exome sequencing detects <i>PYGM</i> variants in two adults with McArdle disease.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">a006173</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1101/mcs.a006173</ELocationID>
        <Abstract>
          <AbstractText>McArdle disease is a debilitating glycogen storage disease with typical onset in childhood. Here, we describe a former competitive athlete with early adult-onset McArdle disease and a septuagenarian with a history of exercise intolerance since adolescence who was evaluated for proximal muscle weakness. Exome sequencing identified biallelic variants in the <i>PYGM</i> gene for both cases. The former athlete has the common, well-known pathogenic variant p.(Arg50Ter) in <i>trans</i> with a novel missense variant, p.(Asp694Glu). The second individual has a previously described homozygous missense variant, p.(Arg771Gln). Here, we describe the clinical course, enzyme-testing results using muscle tissue, and molecular findings for the individuals and add to the knowledge of the genotypic spectrum of this disorder.</AbstractText>
          <CopyrightInformation>© 2022 Thomas-Wilson et al.; Published by Cold Spring Harbor Laboratory Press.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Thomas-Wilson</LastName>
            <ForeName>Amanda</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dharmadhikari</LastName>
            <ForeName>Avinash V</ForeName>
            <Initials>AV</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heymann</LastName>
            <ForeName>Jonas J</ForeName>
            <Initials>JJ</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jobanputra</LastName>
            <ForeName>Vaidehi</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>DiMauro</LastName>
            <ForeName>Salvatore</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hirano</LastName>
            <ForeName>Michio</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Naini</LastName>
            <ForeName>Ali B</ForeName>
            <Initials>AB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Neurology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ganapathi</LastName>
            <ForeName>Mythily</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cold Spring Harb Mol Case Stud</MedlineTA>
        <NlmUniqueID>101660017</NlmUniqueID>
        <ISSNLinking>2373-2873</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>EC 2.4.1.-</RegistryNumber>
          <NameOfSubstance UI="D024982">Glycogen Phosphorylase, Muscle Form</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024982" MajorTopicYN="Y">Glycogen Phosphorylase, Muscle Form</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006012" MajorTopicYN="Y">Glycogen Storage Disease Type V</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000073359" MajorTopicYN="N">Whole Exome Sequencing</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">acute rhabdomyolysis</Keyword>
        <Keyword MajorTopicYN="Y">exercise-induced muscle fatigue</Keyword>
        <Keyword MajorTopicYN="Y">exercise-induced myoglobinuria</Keyword>
        <Keyword MajorTopicYN="Y">recurrent myoglobinuria</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>13</Day>
          <Hour>5</Hour>
          <Minute>55</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35022222</ArticleId>
        <ArticleId IdType="pmc">PMC8958908</ArticleId>
        <ArticleId IdType="doi">10.1101/mcs.a006173</ArticleId>
        <ArticleId IdType="pii">mcs.a006173</ArticleId>
        <ArticleId IdType="medline">MCS006173Tho</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>DiMauro S, Miranda AF, Olarte M, Friedman R, Hays AP. 1982. Muscle phosphoglycerate mutase deficiency. Neurology
32: 584–591. 10.1212/WNL.32.6.584</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1212/WNL.32.6.584</ArticleId>
            <ArticleId IdType="pubmed">6283419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>García-Consuegra I, Rubio JC, Nogales-Gadea G, Bautista J, Jiménez S, Cabello A, Lucía A, Andreu AL, Arenas J, Martín MA. 2009. Novel mutations in individuals with McArdle disease by analysis of skeletal muscle mRNA. J Med Genet
46: 198–202. 10.1136/jmg.2008.059469</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.2008.059469</ArticleId>
            <ArticleId IdType="pubmed">19251976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martín MA, Lucía A, Arenas J, Andreu AL. 2006. Glycogen storage disease type V. In GeneReviews® (ed. Adam MP, Ardinger HH, Pagon RA, Wallace SE). University of Washington, Seattle; 1993–2018. Available from https://www.ncbi.nlm.nih.gov/books/NBK1344/</Citation>
        </Reference>
        <Reference>
          <Citation>Nadaj-Pakleza AA, Vincitorio CM, Laforêt P, Eymard B, Dion E, Teijeira S, Viéitez I, Jeanpierre M, Navarro C, Stojkovic T. 2009. Permanent muscle weakness in McArdle disease. Muscle Nerve
40: 350–357. 10.1002/mus.21351</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.21351</ArticleId>
            <ArticleId IdType="pubmed">19670320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogales-Gadea G, Rubio J, Fernandez-Cadenas I, García-Consuegra I, Lucía A, Cabello A, Garcia-Arumi E, Arenas J, Andreu AL, Martín MA. 2008. Expression of the muscle glycogen phosphorylase gene in individuals with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat
29: 277–283. 10.1002/humu.20649</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.20649</ArticleId>
            <ArticleId IdType="pubmed">17994553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nogales-Gadea G, Brull A, Santalla A, Andreu AL, Arenas J, Martín MA, Lucía A, de Luna N, Pinós T. 2015. McArdle disease: update of reported mutations and polymorphisms in the PYGM gene. Hum Mutat
36: 669–678. 10.1002/humu.22806</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/humu.22806</ArticleId>
            <ArticleId IdType="pubmed">25914343</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petrou P, Pantzaris M, Dionysiou M, Drousiotou A, Kyriakides T. 2015. Minimally symptomatic McArdle disease, expanding the genotype–phenotype spectrum. Muscle Nerve
52: 891–895. 10.1002/mus.24716</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.24716</ArticleId>
            <ArticleId IdType="pubmed">26032558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pizzamiglio C, Mahroo AA, Khan KN, Patasin M, Quinlivan R. 2021. Phenotype and genotype of 197 British patients with McArdle disease: an observational single-centre study. J Inherit Metab Dis
44: 1409–1418. 10.1002/jimd.12438</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jimd.12438</ArticleId>
            <ArticleId IdType="pubmed">34534370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pourmand R, Sanders DB, Corwin HM. 1983. Late-onset McArdle's disease with unusual electromyographic findings. Arch Neurol
40: 374–377. 10.1001/archneur.1983.04050060074014</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.1983.04050060074014</ArticleId>
            <ArticleId IdType="pubmed">6573876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al.
2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med
17: 405–424. 10.1038/gim.2015.30</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId>
            <ArticleId IdType="pmc">PMC4544753</ArticleId>
            <ArticleId IdType="pubmed">25741868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viéitez I, Teijeira S, Fernandez JM, San Millán B, Miranda S, Ortolano S, Louis S, Laforêt P, Navarro C. 2011. Molecular and clinical study of McArdle's disease in a cohort of 123 European individuals. Identification of 20 novel mutations. Neuromuscul Disord
21: 817–823. 10.1016/j.nmd.2011.07.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.nmd.2011.07.002</ArticleId>
            <ArticleId IdType="pubmed">21802952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Lichter-Konecki U, Anyane-Yeboa K, Shaw JE, Lu JT, Östlund C, Shin JY, Clark LN, Gundersen GG, Nagy PL, et al.
2016. A mutation abolishing the ZMPSTE24 cleavage site in prelamin A causes a progeroid disorder. J Cell Sci
129: 1975–1980. 10.1242/jcs.187302</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.187302</ArticleId>
            <ArticleId IdType="pmc">PMC4878994</ArticleId>
            <ArticleId IdType="pubmed">27034136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Withers SG, Madsen NB, Sykes BD, Takagi M, Shimomura S, Fukui T. 1981. Evidence for direct phosphate–phosphate interaction between pyridoxal phosphate and substrate in the glycogen phosphorylase catalytic mechanism. J Biol Chem
256: 10759–10762. 10.1016/S0021-9258(19)68505-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9258(19)68505-4</ArticleId>
            <ArticleId IdType="pubmed">6793586</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
